Literature DB >> 7116078

Plasma folate and affective morbidity during long-term lithium therapy.

A Coppen, M T Abou-Saleh.   

Abstract

In 107 patients on long-term lithium, those with lower plasma folate concentration had a higher affective morbidity than those with higher folate, both at the time and during the previous two years. The association was not the results of weight change or the concomitant use of other drugs. Animal work reporting a decreased synthesis of 5-HT both in folate-deficient animals and in animals fed excessive amounts of folate suggests that it may be important for lithium patients to receive folate supplements to their diet for maximum therapeutic effect.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7116078     DOI: 10.1192/bjp.141.1.87

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  10 in total

Review 1.  Folates and psychiatric disorders. Clinical potential.

Authors:  R Crellin; T Bottiglieri; E H Reynolds
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546

2.  Efficacy of folic acid as an adjunct to lithium therapy on manic-like behaviors, oxidative stress and inflammatory parameters in an animal model of mania.

Authors:  Samira Menegas; Gustavo C Dal-Pont; José H Cararo; Roger B Varela; Jorge M Aguiar-Geraldo; Taise Possamai-Della; Monica L Andersen; João Quevedo; Samira S Valvassori
Journal:  Metab Brain Dis       Date:  2019-12-15       Impact factor: 3.584

Review 3.  Drugs and folate metabolism.

Authors:  D G Lambie; R H Johnson
Journal:  Drugs       Date:  1985-08       Impact factor: 9.546

4.  Effectiveness and outcome predictors of long-term lithium prophylaxis in unipolar major depressive disorder.

Authors:  Christopher Baethge; Philipp Gruschka; Michael N Smolka; Anne Berghöfer; Tom Bschor; Bruno Müller-Oerlinghausen; Michael Bauer
Journal:  J Psychiatry Neurosci       Date:  2003-09       Impact factor: 6.186

5.  Contribution of methotrexate in precipitation of manic episode in bipolar affective disorder explored: a case report.

Authors:  Jayaraman Hariram; Yogaratnam Jegan
Journal:  Ther Adv Psychopharmacol       Date:  2013-08

6.  Modeling gene-by-environment interaction in comorbid depression with alcohol use disorders via an integrated bioinformatics approach.

Authors:  Richard C McEachin; Benjamin J Keller; Erika F H Saunders; Melvin G McInnis
Journal:  BioData Min       Date:  2008-07-17       Impact factor: 2.522

7.  Stability of lithium treatment in bipolar disorder - long-term follow-up of 346 patients.

Authors:  Anne Berghöfer; Martin Alda; Mazda Adli; Christopher Baethge; Michael Bauer; Tom Bschor; Paul Grof; Bruno Müller-Oerlinghausen; Janusz K Rybakowski; Alexandra Suwalska; Andrea Pfennig
Journal:  Int J Bipolar Disord       Date:  2013-07-31

Review 8.  Mitochondrial Agents for Bipolar Disorder.

Authors:  Círia Pereira; Victor Chavarria; João Vian; Melanie Maree Ashton; Michael Berk; Wolfgang Marx; Olivia May Dean
Journal:  Int J Neuropsychopharmacol       Date:  2018-06-01       Impact factor: 5.176

Review 9.  Stress reduction strategies in breast cancer: review of pharmacologic and non-pharmacologic based strategies.

Authors:  Rohit Gosain; Elizabeth Gage-Bouchard; Christine Ambrosone; Elizabeth Repasky; Shipra Gandhi
Journal:  Semin Immunopathol       Date:  2020-09-18       Impact factor: 9.623

10.  Cancer-related stress and complementary and alternative medicine: a review.

Authors:  Kavita D Chandwani; Julie L Ryan; Luke J Peppone; Michelle M Janelsins; Lisa K Sprod; Katie Devine; Lara Trevino; Jennifer Gewandter; Gary R Morrow; Karen M Mustian
Journal:  Evid Based Complement Alternat Med       Date:  2012-07-15       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.